Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,234 | 759 | 1,000 | 791 | 964 |
| Gross Profit | 1,234 | 759 | 1,000 | 791 | 964 |
| Operating Expenses | 5,544 | -340 | 6,826 | 6,059 | 10,759 |
| Operating Income | -4,310 | 1,099 | -5,827 | -5,269 | -9,795 |
| Other Income | 85 | -5 | 100 | 36 | -116 |
| Pre-tax Income | -4,225 | 1,094 | -5,727 | -5,233 | -9,911 |
| Net Income Continuous | -4,225 | 1,094 | -5,727 | -5,233 | -9,911 |
| Net Income Discontinuous | -743 | -4,951 | -1,193 | -4,011 | N/A |
| Net Income | $-4,968 | $-3,856 | $-6,920 | $-9,244 | $-9,911 |
| EPS Basic Total Ops | -0.57 | -0.45 | -0.83 | -1.11 | -1.19 |
| EPS Basic Continuous Ops | -0.48 | 0.14 | -0.69 | -0.63 | -1.19 |
| EPS Basic Discontinuous Ops | -0.09 | -0.60 | -0.14 | -0.48 | N/A |
| EPS Diluted Total Ops | -0.57 | -0.45 | -0.83 | -1.11 | -1.19 |
| EPS Diluted Continuous Ops | -0.48 | 0.14 | -0.69 | -0.63 | -1.19 |
| EPS Diluted Discontinuous Ops | -0.09 | -0.60 | -0.14 | -0.48 | N/A |
| EBITDA(a) | $-4,310 | $1,099 | $-5,827 | $-5,269 | $-8,961 |